Weight-Loss Drug Frenzy Drives Eli Lilly And Novo Nordisk Stock To Record Highs
Shares of pharmaceutical giant Eli Lilly skyrocketed to a record high on Tuesday, after the company reported a surge in sales of its diabetes and weight loss drug Mounjaro, while shares of rival Novo Nordisk also shot up to a record high following a promising clinical trial of its diabetes drug…
#elililly #mounjaro #novonordisk #wegovy #elilillys #danish #novonordisksozempic #obese #fda #mounjarowegovy
